New aspects of the neuroendocrine role of PACAP

K. Köves, J. Molnár, O. Kántor, T. J. Görcs, A. Lakatos, A. Arimura

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The presence of PACAP was revealed in the anterior pituitary with RIA, HPLC, and with the demonstration of its mRNA. The level of PACAP mRNA in the anterior pituitary is the highest during the proestrous LH surge. In our immunohistochemical studies we were able to demonstrate PACAP immunoreactive cells in the anterior pituitary. The shape and the distribution of PACAP immunoreactive cells were very similar to that of the gonadotropes; however, the number of PACAP cells was less than that of LH cells. Additionally, another PACAP-positive cell population with small diameter appeared in the proestrous stage, during pregnancy and lactation. Double labeling revealed that the major part of large PACAP cells exhibited LH immunoreactivity and those with a small diameter contained PRL. It is not clear whether the pituitary- or the hypothalamic-born PACAP, or both, influence pituitary LH and PRL secretion. Icv administration of PACAP just prior to the critical period in the proestrous stage inhibited the expected ovulation and blocked the proestrus LH and PRL surge, although iv administration of PACAP had no effect. PACAP antiserum did not interfere with ovulation when icv or iv injection was used. Our results support the view that PACAP has a role in the control of LH and PRL secretion during the estrous cycle, pregnancy, and lactation. The inhibitory effect of PACAP on ovulation is mediated through the hypothalamus.

Original languageEnglish
Pages (from-to)648-654
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume805
Publication statusPublished - 1996

Fingerprint

Pituitary Adenylate Cyclase-Activating Polypeptide
Ovulation
Gonadotrophs
Lactation
Cells
Proestrus
Pregnancy
Messenger RNA
Estrous Cycle
Labeling
Hypothalamus

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

New aspects of the neuroendocrine role of PACAP. / Köves, K.; Molnár, J.; Kántor, O.; Görcs, T. J.; Lakatos, A.; Arimura, A.

In: Annals of the New York Academy of Sciences, Vol. 805, 1996, p. 648-654.

Research output: Contribution to journalArticle

@article{77bf2e8113574a7ca816f3cf9c5f23f8,
title = "New aspects of the neuroendocrine role of PACAP",
abstract = "The presence of PACAP was revealed in the anterior pituitary with RIA, HPLC, and with the demonstration of its mRNA. The level of PACAP mRNA in the anterior pituitary is the highest during the proestrous LH surge. In our immunohistochemical studies we were able to demonstrate PACAP immunoreactive cells in the anterior pituitary. The shape and the distribution of PACAP immunoreactive cells were very similar to that of the gonadotropes; however, the number of PACAP cells was less than that of LH cells. Additionally, another PACAP-positive cell population with small diameter appeared in the proestrous stage, during pregnancy and lactation. Double labeling revealed that the major part of large PACAP cells exhibited LH immunoreactivity and those with a small diameter contained PRL. It is not clear whether the pituitary- or the hypothalamic-born PACAP, or both, influence pituitary LH and PRL secretion. Icv administration of PACAP just prior to the critical period in the proestrous stage inhibited the expected ovulation and blocked the proestrus LH and PRL surge, although iv administration of PACAP had no effect. PACAP antiserum did not interfere with ovulation when icv or iv injection was used. Our results support the view that PACAP has a role in the control of LH and PRL secretion during the estrous cycle, pregnancy, and lactation. The inhibitory effect of PACAP on ovulation is mediated through the hypothalamus.",
author = "K. K{\"o}ves and J. Moln{\'a}r and O. K{\'a}ntor and G{\"o}rcs, {T. J.} and A. Lakatos and A. Arimura",
year = "1996",
language = "English",
volume = "805",
pages = "648--654",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - New aspects of the neuroendocrine role of PACAP

AU - Köves, K.

AU - Molnár, J.

AU - Kántor, O.

AU - Görcs, T. J.

AU - Lakatos, A.

AU - Arimura, A.

PY - 1996

Y1 - 1996

N2 - The presence of PACAP was revealed in the anterior pituitary with RIA, HPLC, and with the demonstration of its mRNA. The level of PACAP mRNA in the anterior pituitary is the highest during the proestrous LH surge. In our immunohistochemical studies we were able to demonstrate PACAP immunoreactive cells in the anterior pituitary. The shape and the distribution of PACAP immunoreactive cells were very similar to that of the gonadotropes; however, the number of PACAP cells was less than that of LH cells. Additionally, another PACAP-positive cell population with small diameter appeared in the proestrous stage, during pregnancy and lactation. Double labeling revealed that the major part of large PACAP cells exhibited LH immunoreactivity and those with a small diameter contained PRL. It is not clear whether the pituitary- or the hypothalamic-born PACAP, or both, influence pituitary LH and PRL secretion. Icv administration of PACAP just prior to the critical period in the proestrous stage inhibited the expected ovulation and blocked the proestrus LH and PRL surge, although iv administration of PACAP had no effect. PACAP antiserum did not interfere with ovulation when icv or iv injection was used. Our results support the view that PACAP has a role in the control of LH and PRL secretion during the estrous cycle, pregnancy, and lactation. The inhibitory effect of PACAP on ovulation is mediated through the hypothalamus.

AB - The presence of PACAP was revealed in the anterior pituitary with RIA, HPLC, and with the demonstration of its mRNA. The level of PACAP mRNA in the anterior pituitary is the highest during the proestrous LH surge. In our immunohistochemical studies we were able to demonstrate PACAP immunoreactive cells in the anterior pituitary. The shape and the distribution of PACAP immunoreactive cells were very similar to that of the gonadotropes; however, the number of PACAP cells was less than that of LH cells. Additionally, another PACAP-positive cell population with small diameter appeared in the proestrous stage, during pregnancy and lactation. Double labeling revealed that the major part of large PACAP cells exhibited LH immunoreactivity and those with a small diameter contained PRL. It is not clear whether the pituitary- or the hypothalamic-born PACAP, or both, influence pituitary LH and PRL secretion. Icv administration of PACAP just prior to the critical period in the proestrous stage inhibited the expected ovulation and blocked the proestrus LH and PRL surge, although iv administration of PACAP had no effect. PACAP antiserum did not interfere with ovulation when icv or iv injection was used. Our results support the view that PACAP has a role in the control of LH and PRL secretion during the estrous cycle, pregnancy, and lactation. The inhibitory effect of PACAP on ovulation is mediated through the hypothalamus.

UR - http://www.scopus.com/inward/record.url?scp=0030469354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030469354&partnerID=8YFLogxK

M3 - Article

C2 - 8993455

AN - SCOPUS:0030469354

VL - 805

SP - 648

EP - 654

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -